CRBP vs. JANX
CRBP (Corbus Pharmaceuticals Holdings, Inc.) and JANX (Janux Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, CRBP returned -32.59%/yr vs -9.18%/yr for JANX. At a 0.22 correlation, their price movements are largely independent.
Performance
CRBP vs. JANX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRBP achieves a 2.09% return, which is significantly lower than JANX's 3.91% return.
CRBP
- 1D
- 0.61%
- 1M
- -26.78%
- YTD
- 2.09%
- 6M
- -0.36%
- 1Y
- 0.85%
- 3Y*
- -1.85%
- 5Y*
- -32.59%
- 10Y*
- -21.17%
JANX
- 1D
- 0.84%
- 1M
- -1.24%
- YTD
- 3.91%
- 6M
- 1.77%
- 1Y
- -39.24%
- 3Y*
- 4.68%
- 5Y*
- -9.18%
- 10Y*
- —
CRBP vs. JANX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CRBP Corbus Pharmaceuticals Holdings, Inc. | 2.09% | -31.02% | 95.36% | 82.20% | -82.05% | -71.76% |
JANX Janux Therapeutics, Inc. | 3.91% | -74.22% | 398.97% | -18.53% | -33.25% | -41.97% |
Correlation
The correlation between CRBP and JANX is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.33 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.27 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Jun 11, 2021 | 0.22 |
The correlation between CRBP and JANX shifts across timeframes, from 0.22 (all time) to 0.33 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
CRBP:
$155.45M
JANX:
$898.63M
CRBP:
-$5.98
JANX:
-$1.84
CRBP:
1.23
JANX:
0.95
CRBP:
$0.00
JANX:
$21.61M
CRBP:
-$149.00K
JANX:
$8.44M
CRBP:
-$61.36M
JANX:
-$134.03M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRBP vs. JANX — Risk / Return Rank
CRBP
JANX
CRBP vs. JANX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Corbus Pharmaceuticals Holdings, Inc. (CRBP) and Janux Therapeutics, Inc. (JANX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRBP | JANX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.54 | ||
| Sortino ratioReturn per unit of downside risk | +0.84 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 0.96 | +0.13 |
| Calmar ratioReturn relative to maximum drawdown | 0.01 | -0.61 | +0.62 |
| Martin ratioReturn relative to average drawdown | 0.02 | -0.89 | +0.91 |
Loading charts...
Drawdowns
CRBP vs. JANX - Drawdown Comparison
The maximum CRBP drawdown since its inception was -99.31%, which is greater than JANX's maximum drawdown of -83.14%. Use the drawdown chart below to compare losses from any high point for CRBP and JANX.
Loading charts...
Drawdown Indicators
| CRBP | JANX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.31% | -83.14% | -16.17% |
Max Drawdown (1Y)Largest decline over 1 year | -61.88% | -64.94% | +3.06% |
Max Drawdown (3Y)Largest decline over 3 years | -92.01% | -81.78% | -10.23% |
Max Drawdown (5Y)Largest decline over 5 years | -96.55% | -83.14% | -13.41% |
Max Drawdown (10Y)Largest decline over 10 years | -99.31% | — | — |
Current DrawdownCurrent decline from peak | -97.32% | -78.54% | -18.78% |
Average DrawdownAverage peak-to-trough decline | -66.11% | -52.75% | -13.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 41.86% | 44.34% | -2.48% |
Volatility
CRBP vs. JANX - Volatility Comparison
Corbus Pharmaceuticals Holdings, Inc. (CRBP) has a higher volatility of 43.31% compared to Janux Therapeutics, Inc. (JANX) at 9.32%. This indicates that CRBP's price experiences larger fluctuations and is considered to be riskier than JANX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRBP | JANX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 43.31% | 9.32% | +33.99% |
Volatility (6M)Calculated over the trailing 6-month period | 60.26% | 29.29% | +30.97% |
Volatility (1Y)Calculated over the trailing 1-year period | 81.71% | 73.99% | +7.72% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 159.23% | 130.71% | +28.52% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 129.12% | 131.25% | -2.13% |
Dividends
CRBP vs. JANX - Dividend Comparison
Neither CRBP nor JANX has paid dividends to shareholders.
Financials
CRBP vs. JANX - Financials Comparison
This section allows you to compare key financial metrics between Corbus Pharmaceuticals Holdings, Inc. and Janux Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CRBP and JANX have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRBP has higher volatility (43.31%) compared to JANX (9.32%). In terms of maximum drawdown, CRBP dropped -99.31% vs JANX's -83.14%.
CRBP currently has the higher Sharpe Ratio (0.01 vs -0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRBP and JANX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer